Siegfried names Eduardo Montanha COO, effective Sept. 1
PUBT · 1d ago
Share
Listen to the news
- Siegfried appointed Eduardo Montanha as chief operating officer, joining the executive committee from Sept. 1, 2026.
- The move merges COO responsibilities for drug substances and drug products into a single role.
- The company aims to strengthen end-to-end CDMO offerings across the pharmaceutical value chain, from drug substances to drug products.
- Montanha was EVP, head of global technical operations and quality at Fresenius Kabi, overseeing about 30 manufacturing sites worldwide.
- He previously held senior roles in manufacturing, quality, and supply at Takeda, Sandoz, Hexal, Hoechst/Aventis.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Siegfried Holding AG published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2366246_en) on July 16, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved